SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113 | +17.7% | 32,465 | +57.0% | 0.00% | 0.0% |
| Q1 2023 | $96 | -37.7% | 20,678 | +8.8% | 0.00% | -50.0% |
| Q4 2022 | $154 | -99.9% | 19,009 | -11.8% | 0.00% | +100.0% |
| Q3 2022 | $120,000 | +12.1% | 21,543 | +4.9% | 0.00% | 0.0% |
| Q2 2022 | $107,000 | -42.2% | 20,533 | +65.0% | 0.00% | 0.0% |
| Q4 2021 | $185,000 | -66.4% | 12,446 | -57.3% | 0.00% | -66.7% |
| Q3 2021 | $551,000 | +253.2% | 29,162 | +326.3% | 0.00% | +200.0% |
| Q1 2021 | $156,000 | +69.6% | 6,841 | -32.6% | 0.00% | 0.0% |
| Q3 2019 | $92,000 | -57.0% | 10,148 | -46.0% | 0.00% | 0.0% |
| Q2 2019 | $214,000 | -28.7% | 18,808 | -28.7% | 0.00% | -66.7% |
| Q1 2019 | $300,000 | +77.5% | 26,380 | +40.6% | 0.00% | +200.0% |
| Q4 2018 | $169,000 | – | 18,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |